Table 2 Cell death observed in respective cell line and docking score obtained from induced fit docking.

From: A high-throughput screening approach to discover potential colorectal cancer chemotherapeutics: repurposing drugs to identify novel disruptors of 14-3-3 proteins

Compound

%Cell death

Docking score (kcal/mol)

Caco-2

HT-29

Azelnidipine

13.7

91.6

−7.14

Bardoxolone methyl

19.2

67.5

−7.43

Cinacalcet

49.4

70.3

−4.75

Clomiphene

34.7

52.0

−5.21

Doramectin

32.3

51.6

−4.95

Dronedarone

86.9

79.0

−6.48

Efavirenz

20.5

22.0

−3.43

Embelin

1.7

51.8

−4.86

FTY720

67.9

69.1

−6.06

Ivermectin

5.2

78.9

−4.98

Lomitapide

81.7

72.9

−7.48

Moxidectin

8.4

78.4

−3.82

Nebivolol

45.0

67.3

−6.66

Oxethazaine

13.9

53.1

−4.55

Penfluridol

90.0

92.2

−8.31

Pimozide

59.9

64.6

−6.5

Saikosaponin A

1.2

87.6

−6.56

Simeprevir

5.5

70.9

−4.57

Tamoxifen

36.5

63.3

−5.07

Terfenadine

79.7

89.6

−5.91

Vortioxetine

52.1

52.1

−5.31

VX-222 (VCH-222, Lomibuvir)

36.3

78.5

−5.9